Showing 9,741 - 9,760 results of 44,452 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (mean decrease)) ))', query time: 1.39s Refine Results
  1. 9741

    ECA structural model diagram. by Haisong Xu (141729)

    Published 2025
    “…Experimental results in our homemade dataset indicate that the mean average precision (mAP) of ECN-YOLOv5s for bearing defect identification is 92.7%. …”
  2. 9742

    Heat maps for different models. by Haisong Xu (141729)

    Published 2025
    “…Experimental results in our homemade dataset indicate that the mean average precision (mAP) of ECN-YOLOv5s for bearing defect identification is 92.7%. …”
  3. 9743

    Defect category statistics. by Haisong Xu (141729)

    Published 2025
    “…Experimental results in our homemade dataset indicate that the mean average precision (mAP) of ECN-YOLOv5s for bearing defect identification is 92.7%. …”
  4. 9744

    CARAFE general structure. by Haisong Xu (141729)

    Published 2025
    “…Experimental results in our homemade dataset indicate that the mean average precision (mAP) of ECN-YOLOv5s for bearing defect identification is 92.7%. …”
  5. 9745

    lncRNA-GAS5 affects the cell cycle and apoptosis of HSVSMCs. by Li Li (14993)

    Published 2015
    “…<b>C:</b> The apoptosis of HSVSMCs were measured by Flow Cytometry using Annexin V-FITC apoptosis kit. The result shows that the HSVSMCs in early apoptosis decreased with overexpression of lncRNA-GAS5. …”
  6. 9746
  7. 9747
  8. 9748
  9. 9749
  10. 9750
  11. 9751
  12. 9752

    Rescue of <i>MBNL</i>1 e5 and <i>MBNL</i>2 e5 and e8 mis-splicing by erythromycin lactobionate treatment at 10 DPI. by Mougina K. Eltahir (12988153)

    Published 2022
    “…Note the decreased inclusion of <i>MBNL</i>1 e5 (+e5) and <i>MBNL</i>2 e5 (+e5) in DM1 hiNeurons treated with 35 or 65 μM erythromycin for 48 h relative to placebo treated cells. …”
  13. 9753
  14. 9754
  15. 9755

    Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors by Mohamed A. Zeidan (21099628)

    Published 2025
    “…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
  16. 9756

    Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors by Mohamed A. Zeidan (21099628)

    Published 2025
    “…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
  17. 9757

    Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors by Mohamed A. Zeidan (21099628)

    Published 2025
    “…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
  18. 9758

    Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors by Mohamed A. Zeidan (21099628)

    Published 2025
    “…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
  19. 9759

    Shooting an Arrow against Convulsion: Novel Triazole-Grafted Benzenesulfonamide Derivatives as Carbonic Anhydrase II and VII Inhibitors by Mohamed A. Zeidan (21099628)

    Published 2025
    “…Evaluations of toxicity showed no neurotoxic effects and a high safety margin (LD<sub>50</sub> > 2000 mg/kg). …”
  20. 9760